Insulin-Like 5 (INSL5) (Middle Region) Peptide
Quick Overview for Insulin-Like 5 (INSL5) (Middle Region) Peptide (ABIN978567)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- RTVIYICASS RWRRHQEGIP QAQQAETGNS FQLPHKREFS EENPAQNLPK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-INSL5 Antibody(ARP52069_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- INSL5 (Insulin-Like 5 (INSL5))
-
Background
-
The protein encoded by this gene contains a classical signature of the insulin superfamily and is highly similar to relaxin 3 (RLN3/INSL7).
Alias Symbols: MGC126695, MGC126697, PRO182, UNQ156
Protein Size: 135 -
Molecular Weight
- 13 kDa
-
Gene ID
- 10022
-
NCBI Accession
- NM_005478, NP_005469
-
UniProt
- Q9Y5Q6
Target
-